Friedland Jeffrey 4
4 · NEXIEN BIOPHARMA, INC. · Filed Nov 25, 2019
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Gift
Common Stock
2019-11-22−228,800→ 0 total(indirect: By LLC) - Gift
Common Stock
2019-11-22−833,333→ 0 total
Holdings
- 19,000,000(indirect: By Kanativa USA Inc.)
Common Stock
Footnotes (1)
- [F1]The Reporting Person disclaims all beneficial ownership of the securities owned by Kanativa USA Inc., and this report shall not be deemed an admission of beneficial ownership of such securities by the Reporting Person.